Fintech News & Trends in Hong Kong and Asia

Mainland reports 22 imported, 2 local COVID-19 cases

In this March 31, 2021 photo, a resident receives nucleic acid testing for COVID-19 at Mengmao village of Mengmao township, Ruili city, southwest China's Yunnan province. (CHEN XINBO / XINHUA) BEIJING – The Chinese mainland reported 22 imported COVID-19 cases and two locally-transmitted infections on Sunday, the National Health Commission said in its daily report […]

Topelia Australia 發起 2500 萬美元的 A 輪融資,募集資金用於 COVID-19 ATT Ziverdox

SYDNEY, Oct 15, 2021 – (亞太商訊 via SEAPRWire.com) – Topelia Australia 是一家生物技術公司,旨在將一種用於隔離的澳大利亞人的新型 ATT 治療商業化,該公司啟動了一項投資計劃,旨在保留澳大利亞人擁有的發明——同時將治療推廣到世界各地。 Thomas Borody 教授 – Topelia 宣布籌集 2500 萬美元的 A 系列資金,以資助 COVID-19抗病毒三聯療法 (ATT) 的製造和臨床試驗。– Topelia 已從 Thomas Borody 教授那裡獲得 COVID-19 抗病毒三聯療法的全球獨家專利權。– Borody 的業績記錄包括對消化性潰瘍和克羅恩病的有效治療、腸道微生物群的重新定植以及 3 種 FDA 批准的市場上的藥物。– 根據目前的研究,ATT 為 COVID-19 的預防和早期治療提供了一種廉價且醫學上有效的治療方法。– 該公司正在從澳大利亞、亞洲和美國的投資者那裡籌集 2500 萬美元。該公司表示:“Topelia 提議在當前的疫苗接種計劃的同時提供 ATT 治療,以治療和接種我們的疫苗以擺脫這種大流行。隨著澳大利亞解除封鎖,世界各國的病例激增,因此快速-至關重要 跟踪安全的早期抗病毒藥物治療套件的生產。 新型抗病毒三聯療法,將被命名為 Ziverdox,包括幾十年來 TGA 批准的具有特殊安全性的藥物。 […]

Mainland reports 26 imported virus cases, 2 local infections

Medical workers collect swab samples from students for nucleic acid testing at a school in Fuzhou, Fujian province. (LYU MING/CHINA NEWS SERVICE) BEIJING – The Chinese mainland reported 26 imported COVID-19 cases and two locally-transmitted infections on Saturday, the National Health Commission said in its daily report on Sunday. One of the newly-added local cases […]

A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes

SINGAPORE, Sep 30, 2021 – (ACN Newswire via SEAPRWire.com) – The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health […]